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Introduction

Growth of an animal results from the interaction of its genetic potential with
environmental conditions (Bauer et al., 1995). The environment, in regards to fetal
growth, consists of many variables. This study focuses on in-utero conditions, which
largely depend on placental transfer (Longtine et al., 2011). Normal placental growth,
which is an important precursor to adequate placental function, is essential, as the
placenta is responsible for the transfer of all nutrients, including oxygen, from the mother
to the fetus (Longtine et al., 2011). Specifically, placental insufficiency results in reduced
nutrient transfer, increased potential for hypoxic conditions, and increased occurrence of
intrauterine growth retardation (IUGR) of the fetus (Bell and Ehrhardt, 2002; Gluckman
and Hanson, 2004; Wallace et al., 2004). However, if nutrients are not plentiful in
maternal circulation, or altered concentrations of hormones are present, fetal growth can
still be hindered (Wu et al., 2006).
Intrauterine Growth Retardation
Intrauterine growth retardation is defined as impaired growth and development of
the mammalian embryo/fetus or its organs during pregnancy (Wu et al., 2006). According
to Wu et al (2006), from a statistical standpoint, an organism must weigh at least two
standard deviations less than the mean to be considered IUGR. It results in smaller
offspring and negative long-term consequences in the offspring such as insulin resistance,
Type-2 diabetes, obesity, hypertension, altered organ size, and poor meat quality due to
an increased ratio of adipose tissue to muscle tissue (Ong et al., 2000; Wu et al., 2006;
Tosh et al., 2010).
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In the livestock industry, this results in animals with poor meat quality, with
increased adipose tissue accretion at the expense of muscle tissue (Boersma and Wit,
1997). This produces a product that is less healthy, and less palatable, and therefore is
less in demand by the consumer. Additionally, the cost to raise this animal to slaughter is
greater, as its feed efficiency, or the amount of feed required for the animal to gain
muscle, is reduced. There are also implications of IUGR in humans. Metabolic syndrome
is prevalent, and perhaps maternal diet during gestation is responsible. It is hypothesized
that these symptoms of metabolic syndrome stem from modifications made to the
somatotropic axis, the hormonal system responsible for the regulation of growth, and
modifications to other metabolic pathways, to enhance fetal survival (Thorn et al., 2011).
The focus of my research was on IUGR as a result of poor maternal nutrition, due
to both under-feeding and over-feeding of the mother. Sheep were used as a model to
study concerns to both the livestock industry and to human health. As sheep are
ruminants, they model the effects to production animals. Before weaning, however, the
rumen is not fully developed, and the sheep can model effects of a monogastric animal,
such as humans.
Vonnahme et al. (2003) used sheep as a model, and determined that nutrient
restriction of 50% of the nutrient requirements suggested by the National Research
Council (National Research Council, 1985) for a pregnant ewe from days 28 to 78 of
gestation results in IUGR of the fetus, as displayed by a 105 g decrease in fetal weight on
day 78 of development. Over-nutrition of the ewes also imparted negative effects. Overnourished ewes had a placenta that was reduced in size by 40%, and in addition, carried
lambs of low-birth-weight from 128 days of gestation to term (Wallace et al., 1996, 1997,
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2000). This suggests that the over-nourished, pregnant ewe partitions nutrients toward
maternal fat deposition, rather than toward placental and fetal development (Wallace et
al., 2000).
In this literature review, I will discuss the somatotropic axis, insulin signaling
pathways, as well as the leptin pathway during normal fetal development and postnatal
growth. I will also be discussing the role each pathway may have in the phenomenon of
IUGR, and the specifics of these hypotheses.
The Somatotropic Axis
The somatotropic axis includes hormones secreted from the hypothalamus, the
anterior pituitary gland, the liver, and other body tissues as well as their receptors; it is
responsible for the regulation of growth (Renaville et al., 2002). Growth hormone
releasing hormone (GHRH) is released from the hypothalamus in response to reduced
circulating concentrations of growth hormone (GH), a 191 amino acid protein hormone
(Secci and Borromeo, 1997). Growth hormone is secreted in a constant pulsatile manner
from the anterior pituitary gland (Zinn et al., 1994; Tuggle and Trenkle, 1996).
Somatostatin (SRIF), on the other hand, is released from the hypothalamus in response to
an excess of circulating GH; together, these act as a negative feedback loop to maintain
homeostasis in circulating GH and insulin-like growth factor -1 (IGF-1) concentrations
(Zinn et al., 1994; Tuggle and Trenkle, 1996).
Growth hormone has both direct and indirect effects on body tissues. It directly
results in triglyceride breakdown, and prevention of lipid accumulation in adipocytes
(Garten et al., 2012). Its actions are mediated through binding to GH receptors (GHR),
which bind to cell-surface receptors of the tyrosine kinase JAK2 families, to initiate its
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numerous cellular functions (Baumann, 1994; Wojcik et al., 1995; Renaville et al., 2002).
Increased GH concentrations also cause the liver and local tissues to release IGF-1
(Bloomfield et al., 2006), which acts to directly stimulate growth of target tissues bone
and muscle, while acting as a negative control of GH (Yakar et al., 1999). Insulin-like
growth factor-1 also indirectly inhibits GH by stimulation of SRIF secretion (Zinn et al.,
1994; Tuggle and Trenkle, 1996).
Placental Lactogen
During gestation, maternal GH is gradually replaced by placental (p)GH (Igout et
al., 1995). Placental GH is responsible for reducing maternal insulin sensitivity by 45 to
70%, which serves to prevent normal nutrient partitioning to maintain the fetal nutrient
supply (Freemark, 2006). This means that insulin resistance is induced by pGH to ensure
that not all maternal nutrients are transported into cells, but that enough are left in
circulation to support a growing fetus (Newbern and Freemark, 2011). The increased
nutrient transfer increases fetal insulin and IGF-1 concentrations, which promote fetal
growth (Murphy et al., 2006). It does not appear that pGH is regulated by GHRH, but is
secreted tonically (Baumann, 2009). Mannik et al. (2010) found decreased mRNA
transcript for pGH associated with infants born small for gestational age (SGA),
suggested dysregulation of the somatropic axis. Placental GH has not been found in the
fetal circulation (Newbern and Freemark, 2011).
IGF-1
Insulin-like growth factor-1 is a 70 amino acid protein (Rinderknecht and
Humbrel, 1978). Growth is stimulated when IGF-1 and IGF-2 bind to the IGF-1 receptor,
which stimulates bone and muscle development through a tyrosine kinase signaling
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cascade (Liu et al., 1993). Growth hormone directly stimulates prechondrocyte
production while IGF-1 is directly responsible for development of new bone (Isaksson et
al., 1987). Therefore, only IGF-1 and GH together result in normal bone growth. There is
a similar mechanism of action in muscle accretion; GH stimulates amino acid uptake, the
precursor to muscle accretion, while IGF-1 is responsible for actual protein synthesis
(Norrelund, 2005).
For growth to occur, cooperation between GH and IGF-1 is required. It was found
that IGF-1-null mice experience 40% reduced growth, whereas IGF-1 receptor-null mice
experience 55% reduced growth, reduced organ size, reduced muscle development, and
delayed bone development; they are not viable and die of respiratory failure (Liu et al.,
1993). Inactive GH receptors result in a lack of production of IGF-1, causing Laron
dwarfism (Laron et al., 1966) whereas overproduction of GH, and therefore IGF-1 is the
cause of acromegaly (Melmed et al., 1983). The discrepancy in the amount of growth
reduction means that GH is capable of inducing some growth on its own, but cooperation
with IGF-1 is required for normal growth. Mice lacking only hepatic IGF-1, however,
experience normal growth, which confirms the importance of the autrine/paracrine
actions of local IGF-1 (Yakar et al., 1999).
Insulin-like growth factor-1 can also bind to the insulin receptor due to their
structures being 70% homologous, and can stimulate insulin-like actions (Rinderknecht
and Humbel, 1978; Zapf et al., 1986). These actions include stimulation of glucose
transport via translocation of the GLUT4 glucose transporter to the cell surface (Zapf et
al., 1986). The GLUT4 transporter is responsible for the uptake of glucose from the
circulation into the cell. IGF-2 can also induce growth through the AKT and MAP-kinase

7

pathway by binding to the insulin receptor (Somwar et al., 2001). Postnatally, GH and
IGF-1 are the ligands primarily responsible for growth, but IGF-2, which is responsive to
PGH, rather than fetal GH, is the hormone responsible for fetal development (Gluckman
and Pinal, 2003).

IGF Binding Proteins (IGFBP)
The IGFBP are a family of binding proteins produced by the liver (Govoni et al.,
2005), that bind to IGF and modulate its activity (Breier, 1999). Insulin-like growth
factor binding proteins -1, -2, -4, and -6 are known to inhibit the actions of IGF-1, and
restrict growth by binding to IGF to prevent binding to receptors (Govoni et al., 2005). In
contrast, IGF-3 and -5 are known to stimulate the action of IGF-1, and promote growth
by binding in a ternary complex with an acid labile subunit (Govoni et al., 2005; Sabin et
al., 2011). Osteoporosis, or reduced bone mineral density (BMD), is associated with an
increase in inhibitory proteins, IGFBP-1, -2, -4, and -6, and a decrease in stimulatory
proteins, IGFBP-3, and -5, as well as IGF-1 (Jehle et al., 2003).
The association with IUGR and the IGFBP lies in part, in the availability of IGF.
The IGFBP have a greater binding affinity for IGF than do the IGF receptors, and only a
small amount of circulating IGF is unbound and bioactive (Kawai and Rosen, 2012). In
offspring born to nutrient-restricted or overfed mothers, it is expected that reduced
growth, would predominate as a response to reduced IGF-1. However, increased
concentrations of the inhibitory IGFBP would also work to reduce the amount of
bioactive IGF, resulting in a similar outcome.
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Insulin-like growth factor binding protein-3 also has IGF-independent actions. It
can translocate to the nuclear membrane and bind to retinoid X receptor α (RXRα) and
peroxisome proliferator-activated receptor γ (PPARγ), both of which modulate adipocyte
differentiation (Chan et al., 2009). This inhibits the differentiation of adipocytes,
preventing their maturation (Chan et al., 2009). Insulin-like growth factor binding
protein-3 reduces insulin-stimulated glucose uptake by reducing glucose uptake by
GLUT4 transporters, in part by inhibiting GLUT4 transporter translocation (Chan et al.,
2005). Insulin resistance is also induced by a mutant form of IGFBP-3 with an altered
nuclear localization sequence (NLS), that prevents it from being able to tanslocate to the
nucleus or bind to RXRα (Chan et al., 2005). All of this results in insulin resistance and
impaired glucose when IGFBP-3 is overexpressed (Silha et al., 2002).
During fetal development IGFBP-2 is the IGFBP primarily expressed (Shimasaki
and Ling, 1991). However, postpartum IGFBP-2 concentrations are inversely related to
body mass index (Mattsson et al., 2008). Therefore, it is inversely correlated with
adiposity-related insulin resistance, or metabolic syndrome (Heald et al., 2006).
Our research focuses on IGFBP-2 and -3 because they have been noted to be
impacted by both nutrition and stage of development in ruminants (Breier, 1999; Govoni
et al., 2003).
Other Affected Metabolic Pathways
Other metabolic pathways affected by IUGR include glucose metabolism and
leptin signaling. This alteration could be due to altered receptor number, altered
metabolite concentration, or numerous other variables such as mRNA expression and
epigenetic modifications.

9

The body responds to increased blood glucose concentrations by secreting insulin
from pancreatic β cells (Yuan et al., 2011). Insulin aids in the facilitated diffusion of
glucose from the blood into the cells by GLUT transporters; this provides energy for
cellular respiration and keeps blood glucose concentrations relatively stable (Zapf et al.,
1986). Insulin also works to stimulate glycogenesis, the process by which glucose is
converted to glycogen, a compound that can be stored in the liver for later energy
conversion (Zapf et al., 1986).
Leptin is a 16kDa protein secreted by adipose tissue and coded for the the ob gene
(Zhang et al., 1994). Leptin acts on the hypothalamus to suppress appetite, inhibit feed
intake, and increase energy expenditure (Yura et al., 2005). In ruminants, receptors are
specifically expressed in the hypothalamus, anterior pituitary gland, and adipose tissue
(Dyer et al., 1997). In well-fed ewes, there are fewer hypothalamic receptors for leptin
expressed than in nutrient-restricted ewes (Dyer et al., 1997). It was also determined that
plasma leptin concentration was positively correlated to body weight, body condition
score, and adiposity, so it is therefore primarily known as a marker of organism adiposity
(Delavaud et al., 2000). Thus, increased circulating leptin, either as a function of fewer
receptors or as a function of leptin resistance is associated with obesity. This holds true
for humans as well; infants born SGA who experience postnatal compensatory growth
have greater total body fat, and increased circulating leptin concentrations as adults, than
infants born at a normal weight (Phillips et al., 1999).
Nutrition-Induced Changes to Regulation of Growth and Metabolism
When a gestating mother is in a period of nutritional stress, IGF-1 concentrations
decrease, resulting in increased pGH concentrations (Baumann, 2009); this results in
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nutrient partitioning in favor of the mother, and a fetus with decreased circulating IGF-1
and reduced growth (Sjogren et al., 1999; Yakar et al., 1999; Tosh et al., 2010). Fetal
nutrition increases both fetal IGF and fetal insulin, and the concentrations of the two are
correlated (Baumann, 2009). Fetal pancreatectomy resulted in significantly reduced
plasma IGF-1, while simultaneously increasing IGF-2 activity (Gluckman et al., 1987).
Concentrations of GH are increased in response to reduced IGF-1 concentrations, as is
consistent with a negative feedback loop (Giustina et al., 2008). IGF-1 concentrations are
also positively correlated with BMD, so when IGF-1 is reduced, BMD should be reduced
as well (Mohan et al., 2003; Govoni et al., 2005).
Over-nutrition of adolescent ewes can also lead to IUGR in their offspring
(Wallace et al., 1996, 2004). This occurs through nutrient partitioning away from both
placental and fetal growth, and toward maternal growth, resulting in reduced placental
and fetal size (Wallace et al., 2004; Lea et al., 2005). Lea et al. (2005) found that on day
81 of gestation, overnourished adolescent ewes exhibited reduced placental growth, and
increased level of the pro-apoptotic protein bax, when compared with the control. This
means that at day 81 of gestation, placental cells from overnourished adolescent ewes are
not growing as they should be, due to an increased ratio of cells undergoing apoptosis, to
proliferating cells.
Hypotheses of the Mechanism of Action
Changes to the pregnant mother result in changes in the fetus. There are three
hypotheses suggesting possible mechanisms behind these fetal changes: the Fetal Insulin
Hypothesis, the Thrifty Phenotype Hypothesis, and the Predictive Adaptive Response
Hypothesis. The Fetal Insulin Hypothesis suggests that insulin resistance, glucose
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intolerance, diabetes, and hypertension are all phenotypes of the same insulin-resistant
genotype (Hattersley and Tooke, 1999). A mutation in the glucokinase gene of the fetus
resulted in reduced birth weight, suggesting that a mutation in this same gene in the
mother would result in reduced maternal insulin secretion, and therefore hyperglycemia
(Hattersley et al., 1998). This would then lead to a period of increased fetal growth and
insulin secretion postpartum (Byrne et al., 1994). These hypotheses were proven valid at
birth, when it was determined that the effects of these mutations were additive, but Vehlo
et al. (2000) determined that these effects did not persist into adulthood.
An alternative insulin-resistant genotype results from an absent allele of a
polymorphism in the promoter region of the IGF-1 gene, resulting in reduced insulinsecreting capacity as well as in reduced circulating IGF-1 concentrations, reduced adult
height, and increased risk of heart attack and Type-2 diabetes (Vaessen et al., 2001,
2002). Larnkjaer et al. (2009), however, found an inverse relationship between IGF-1
concentrations at 9 months of age and 17 years of age between breast-fed and formulafed humans. A greater IGF-1 serum concentration at 9 months in formula-fed individuals
corresponded to a reduced IGF-1 concentration at 17 years old (Larnkjaer et al., 2009).
This finding, that the mutation fixes itself, suggests that the changes that occur in
hormonal axes are due to metabolic programming, rather than genetic differences. This is
especially interesting because human babies that were nursed had reduced risk of obesity
later in life than formula-fed babies (von Kries et al., 2000), suggesting that the mother
regulates intake of the offspring. The increased IGF-1 serum concentration at 9 months in
the formula-fed individuals would therefore correspond with increased nutrients and
increased fetal insulin. Thus, this model is similar to that of a nutrient-restricted fetus
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being introduced to an environment of adequate nutrition, in terms of metabolic
programming. This finding lends credence to the Thrifty Phenotype Hypothesis.
The Thrifty Phenotype Hypothesis is the more accepted hypothesis, and was
originally asserted by Hales and Barker (1992). This hypothesis suggests that permanent
changes in glucose-insulin metabolism stem from effects of poor nutrition during fetal
and early life (Hales and Barker, 1992). Prenatal modifications to metabolism selectively
alter the growth rates of body tissues, sparing nutrient availability for the brain at the
expense of other organs, including the pancreas, kidneys, liver, and lungs (de Boo et al.,
2008; Yuan et al., 2011; Novitskaya et al., 2011). The metabolic setting of these organs is
also altered by IUGR, which essentially programs the fetus to thrive in an environment
with poor nutrient availability (Barker, 1997). Thus, poor gestational nutrition enhances
the ability of the fetus to absorb and use nutrients (Hales and Barker, 1992). Whereas
these modifications enhance fetal survival, they lead to negative health consequences as
they persist into adulthood (Wu et al., 2006). This is known as fetal programming, which
is defined by Lucas (1991) as when a provocation at a vital stage of development results
in changes that last the lifetime of the individual. It is also known as the developmental
origins of health and disease (Barker, 1997). The somatotropic axis, as well as glucose
metabolism and leptin signaling are all potentially reprogrammed during gestation by
IUGR (Thorn et al., 2011).
The Predictive Adaptive Response Hypothesis was asserted by Gluckman and
Hanson (2006). It is an offshoot of the Thrifty Phenotype Hypothesis and suggests that
the maternal uterine environment serves as a prediction of the postnatal nutritional
environment (Gluckman and Hanson, 2006). While the Thrifty Phenotype Hypothesis
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stresses the negative consequences that IUGR has on long-term animal health, the
Predictive Adaptive Response Hypothesis views fetal programming as advantageous to
the offspring. Depending on the external environment, either interpretation can be
correct.
Compensatory Growth
Due to the thrifty phenotype and fetal programming, IUGR newborns are smaller
at birth, but tend to undergo rapid postnatal growth, known as compensatory growth,
once adequate nutrition becomes available (Ong et al., 2000; Tosh et al., 2010). However,
due to alterations made during fetal programming of metabolism, nutrient partitioning,
and endocrine regulation, this rapid growth often causes obesity in adulthood in IUGR
animals (Tosh et al., 2010; Thorn et al., 2011). This results in increased body fat,
decreased lean muscle mass, increased insulin resistance, and eventually in diabetes (Wu
et al., 2006). Compensatory growth is defined as a growth rate above that which is
statistically normal, during a period of time immediately following growth inhibition
(Boersma and Wit, 1997). As a result, the individual resumes its original growth
trajectory from before the restriction. Compensatory growth essentially occurs through
increased feed intake, which increases IGF-1 concentrations above normal (Boersma and
Wit, 1997). Once the normal trajectory has been achieved, intake decreases, and IGF-1
concentrations resume to normal (Boersma and Wit, 1997). For this reason, in animals
undergoing compensatory growth, body weight is inversely correlated to IGF-1
concentrations (Fall et al., 1995).
Compensatory growth also results in obesity and other metabolic disorders
(Boersma and Wit, 1997; Wu et al., 2006; Bol et al., 2008). An animal programmed to
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best absorb nutrients in an environment not conducive to growth will be programmed for
obesity and reduced health when nutrition is plentiful (Bol et al., 2008; Setia and Sridhar,
2009). When nutrient restriction is maintained postpartum, compensatory growth is
postponed, and the negative consequences associated with metabolic syndrome do not
occur (Tosh et al., 2010). It was found that IUGR animals had similar concentrations of
hepatic IGF-1 mRNA to the control group when nutrient restriction was maintained
postpartum (Tosh et al., 2010). Therefore, restriction of postpartum nutrition and
regulation of the rate of compensatory growth may prevent any epigenetic modifications
related to IUGR that may lead to metabolic syndrome and its negative impacts (Tosh et
al., 2010).
Changes to Fetal Growth and Metabolism
During gestation, a fetus of an underfed ewe experiences reduced circulating
concentrations of insulin, IGF-1, IGF-2, and IGFBP-3, along with increased
concentrations of GH and IGFBP-1 and -2 (Giudice et al., 1995; de Zegher et al., 1997;
Renaville et al., 2002). At 9 months of age in IUGR rats fed ad libitum postpartum, it was
noted that an increased concentrations of plasma IGF-1 were present (Tosh et al., 2010).
In another study, Vonnahme et al., (2003) found that increased concentrations of IGF-1
coincided with reduced body weight and size at birth in lambs. However, Coupé et al.,
(2012) saw differences in size of rats similar to the Vonnahme group, yet this difference
was lost by 5 months of age. This is in part due to the effects of compensatory growth
(Boersma and Wit, 1997).
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Changes in Gene Expression
Compensatory growth results in increased hepatic IGF-1 mRNA expression (Tosh
et al., 2010). It is suggested that increased amounts of mRNA are due to IGF-1 histone
and chromatin structure modifications to the methylation of the fourth lysine residue of
histone three (H3K4; Tosh et al., 2010). This suggests that compensatory growth results
in epigenetic changes to chromatin and histone structure. Additionally, there are two IGF1 isoforms, which stem from alternative splicing of the six IGF-1 exons; fasting, diabetes,
and development all result in different transcriptional start sites through epigenetic
modifications (Adamo et al., 1991; Tosh et al., 2010). Therefore, epigenetic
modifications to histone structure can alter access of transcriptional machinery to the
DNA and could therefore cause differential transcription of isoforms, both in terms of
start site and amount of mRNA transcribed (Cheung and Lau, 2005; Feil, 2006). For
example, trimethylation of H3K4 has been established as a marker on promoter regions
of active genes, whereas dimethylation is associated with promoting expression and
recruitment of transcriptional machinery (Santos-Rosa et al., 2002; Cheung and Lau,
2005).
Rats exhibiting IUGR given adequate nutrition postpartum, displayed increased
mRNA expression of both isoforms of IGF-1 at 9 months of age (Tosh et al., 2010). This
is associated with decreased H3K4 dimethylation at the IGF-1 promoters 1 and 5, and
increased H3K4 at untranslated region 4 (Tosh et al., 2010). However, IUGR rats with
postpartum feed restriction only displayed increased mRNA expression of IGF-1B at 9
months of age (Tosh et al., 2010). This coincided with reduced H3K4 demethylation at
IGF-1 promoter 1 and increased dimethylation at both promoter 2 and untranslated region
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3 (Tosh et al., 2010). At birth, there was no significant difference in mRNA expression
between treatment groups, but there was increased H3K4 dimethylation at promoter 1,
exon 5, and untranslated region 3 in nutrient restricted rats at this time (Tosh et al., 2010).
It has been determined in the laboratory that Cited 1 gene knockout mice develop
late gestational placental insufficiency, as the Cited 1 gene is responsible for trophoblast
development (Rodriguez et al., 2004). This is one model of experimentally inducing
IUGR in a fetus. Cited 1 is X-linked, allowing researchers to distinguish placental from
embryonic effects (Novitskaya et al., 2011). In the Cited 1 knockout model, there was a
reduction of fetal IGF-1 receptors (IGF-1R) as well as fetal insulin receptors in the
kidneys, and a reduced number of insulin receptors in the lungs and liver of mice pups
born to Cited 1 knockout dams (Novitskaya et al., 2011). There was no change in IGF-1R
in the brain, which means that the change in phosphorylation is due solely to placental
insufficiency (Novitskaya et al., 2011). The change in phosphorylation in the kidneys and
lungs was due to alterations of IGF-1 and -2 expression, while liver changes were
associated with decreased pancreatic insulin secretion (Novitskaya et al., 2011). This
model of inducing IUGR allows researchers to determine which effects of IUGR are due
to solely placental insufficiency, and which have more compound causes
In the sheep model, placental restriction induced by caruncle removal increased
peri-renal leptin expression, but not receptor expression at day 43 postpartum (De Blasio
et al., 2010). Plasma leptin concentrations at day 40 in fed lambs correlated with perrenal leptin expression in both IUGR and control lambs, but with receptor expression
only in IUGR lambs (De Blasio et al., 2010), suggesting dysregulation between
circulating leptin concentrations and receptor amounts. Thus, these animals are primed
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for hyperleptinemia, and leptin insensitivity. In fasted lambs, such a change was not
noted (De Blasio et al., 2010). Peri-renal leptin expression was positively correlated with
visceral fat mass, as a percentage of body weight in IUGR lambs (De Blasio et al., 2010).
Plasma leptin concentration, however, correlated positively with total visceral fat mass,
and with total visceral fat mass as a percentage of body weight (De Blasio et al., 2010). It
is also interesting to note that in a 1.5 hour observation period on day 15, leptin
concentration correlated negatively with the total number of suckling events in lambs
born to control-fed ewes (De Blasio et al., 2010). In contrast, leptin concentration
correlated positively with total suckling time in lambs that experienced placental
restriction (De Blasio et al., 2010). When adjusted for body weight, leptin concentration
also correlated positively with total number of suckling events in placentally-restricted
lambs (De Blasio et al., 2010). This points to leptin insensitivity, and the possibility that
these lambs will become obese later in life.
Bol et al. (2008) altered protein composition of the diet of rat dams during
gestation, and induced compensatory growth in pups by reducing the number of pups per
litter. The group compared adiposity of rats born to dams fed low a protein diet with rats
born to control-fed dams during gestation (LP rats) and found an increased number of
preadipocytes in LP animals, and increased Cyclin D1 mRNA expression (Bol et al.,
2008). The preadipocytes from male rat pups at four weeks of age were harvested and
cultured; it was found that total DNA and protein within the preadipocytes of LP rats at
days 4, 7, and 9 of culture was increased, suggesting altered adipocyte
growth/development (Bol et al., 2008). However, no difference was noted at later days of
culture (Bol et al., 2008). At this time, LP rats also displayed decreased mRNA
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expression of PPARγ and SREBP-1 mRNA, which are regulators of adipocyte
differentiation (Hausman et al., 2001; Bol et al., 2008). This makes sense, since
differentiation and proliferation cannot occur simultaneously (Bol et al., 2008). These
results suggest that at 4 weeks in vivo, LP rats are experiencing increased proliferation of
preadipocytes, which will eventually mature into adipocytes, resulting increased total fat
mass.
Insulin Resistance/Glucose Intolerance/Type-2 Diabetes
Offspring that are IUGR due to maternal feed restriction, experience reduced
insulin concentrations while in-utero, which presents a lack of stimulus for the
development of the insulin-receptor system (Hales and Barker, 1992; Guidice et al.,
1995). Fewer insulin receptors results in reduced glucose clearance from the blood, and
therefore increased circulating glucose (Guidice et al., 1995). It is suggested that the
GLUT4 transporter, which is responsible for glucose uptake into cells, is also impaired
(Jaquet et al., 2001). This is because in peri-renal fat of lambs energy-restricted in utero,
proteins for insulin-receptor β (Irβ) and the p110β isofrm of P13-kinase in the
phosphotidylinositol pathway were increased (Gardner et al., 2005). These proteins are
responsible for translocating GLUT4 transporters to the cell surface of adipocytes, so
theoretically, GLUT4 protein should be increased; however, GLUT4 protein was
decreased (Gardner et al., 2005). In muscle, only the Irβ protein was significantly
decreased (Gardner et al., 2005). This demonstrates dysregulation between signaling for
GLUT4 protein in adipose tissue, and its expression. Additionally, GLUT4 expression
and its mRNA expression in adipose tissue was not stimulated by the presence of
circulating insulin in humans born IUGR, as it was in controls (Jaquet et al., 2001).
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Impaired GLUT4 transporter function means that adipose tissue is not as capable to clear
glucose from the circulation and bring it into the cell.
Yuan et al. (2011) reported that from birth to 15 weeks of age, both glucose
tolerance and insulin sensitivity decreased in IUGR rats when compared with controls. In
this experimental design, IUGR was induced by reducing maternal caloric intake by 50%
from days 11 to 21 (mid-late) gestation (Yuan et al., 2011). At birth, the IUGR group
exhibited increased glucose tolerance and increased insulin sensitivity, as the fetus was
programmed to maximize nutrient uptake as a result of a poor gestational environment;
however, with age, this trend reversed (Yuan et al., 2011). In a glucose tolerance test, in
which glucose is injected into the blood stream at birth to determine the time it takes for
glucose clearance and the magnitude of the insulin response, the IUGR group displayed
increased blood glucose and insulin concentrations at 120 and 180 minutes after glucose
injection (Yuan et al., 2011). However, by 15 weeks, this same test resulted in increased
concentrations of both, compared with controls, after only 30 minutes (Yuan et al., 2011).
At 15 weeks, IUGR rats responded to insulin injection with a 40% decrease in blood
glucose concentration, compared with the 50% decrease exhibited by the control group,
suggesting both decreased insulin response and decreased insulin sensitivity in IUGR rats
(Yuan et al., 2011). The pancreas was harvested from animals of both treatments groups,
and was found to weigh less as a percentage of body weight in the IUGR group than the
control group. Long et al. (2009), however, did not observe this trend in cattle. The β
cells of harvested pancreas were cultured and exposed to two different concentrations of
glucose (Yuan et al., 2011). It was expected that there would be a greater insulin response
to the larger concentration of glucose; however the IUGR group displayed significantly
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reduced insulin response to the greater glucose concentration (Yuan et al., 2011). This
suggests that in IUGR animals, pancreatic β cells were less developed, or less responsive
than the control animals.
In lambs from ewes nutrient restricted to 50% NRC requirements from day 28 to
78 of gestation, baseline glucose concentrations at 1 day of age were significantly
increased, but basal insulin was not different (Ford et al., 2007). However, at 250 days of
age, baseline glucose and insulin concentrations did not differ between IUGR lambs and
control lambs (Ford et al., 2007). Growth-restricted lambs did exhibit a decreased insulin
area under the curve (AUC), and a greater AUC for glucose (Ford et al., 2007). This
suggests reduced insulin sensitivity (Ford et al., 2007). At one year of age, lambs energyrestricted until day 30 of gestation, and in lambs from ewes underfed from 110 days of
gestation to parturition, showed similar responses to glucose tolerance tests (Gardner et
al., 2005). Maximal change in glucose and insulin concentrations and time to return to
baseline glucose concentrations in response to a glucose challenge were similar as well
(Gardner et al., 2005). Feed restriction to 50% NRC requirements of ewes during the last
37 days of gestation results in reduced insulin sensitivity in the offspring at 12 months of
age (Gardner et al., 2005), because it took longer for the insulin concentration to return to
baseline after a glucose challenge in these lambs, since less overall insulin was released,
and less glucose was removed from the blood.
Obesity
Growth-restricted rats allowed to feed ad libitum exhibited rapid compensatory
growth and increased circulating triglyceride concentrations at birth, but decreased
concentrations of glucose, insulin, and triglycerides at three weeks (Desai et al., 2007).
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By 9 months, these metabolites were all increased (Desai et al., 2007). Insulin deficiency
and increased cholesterol were exhibited in rats allowed delayed compensatory growth by
restricting feed postpartum (Desai et al., 2007). This programmed obesity is perhaps due
to leptin resistance, as lambs from nutrient-restricted ewes (day 28 to 78 of gestation) had
increased leptin concentrations (Ford et al., 2007). Leptin has a characteristic peak during
development that has been found to program its own axis and sensitivity (Yura et al.,
2005). In sheep, this peak is from day 6 to 9 postpartum (Long et al., 2011). In lambs
from overfed ewes, however, this peak was from days 0 to 4 postpartum (Long et al.,
2011).
In rats, offspring of obese dams have an amplified and prolonged leptin peak
when compared with offspring from control dams (Kirk et al., 2009). In rats administered
leptin before the time of the leptin peak, the number of leptin receptors was reduced in
the hypothalamus (Toste et al., 2006). Fewer leptin receptors results in a reduced
response to leptin in these rats, and could result in leptin resistance (Yura et al., 2005).
IUGR rats experienced an earlier leptin surge than control rats and exhibited increased
appetite despite increased circulating leptin (Vickers et al., 2000; Yura et al., 2005). Since
the role of leptin is to decrease appetite, decrease feed intake, and increase activity, this
finding suggests leptin resistance (Vickers et al., 2000; Yura et al., 2005).
Lambs with an abnormal leptin peak experienced an increase in appetite, similar
to the behavior expressed by rats with reduced leptin receptors, and leptin insensitivity
(Yura et al., 2005; Long et al., 2010, 2011). It is hypothesized that perhaps the early
leptin peak is due to increased leptin mRNA in adipose tissue (Kirk et al., 2009). It is also
possible that this is related to increased cortisol in obese sheep compared with the
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controls. For example Long et al. (2011) reported obese ewes lambed approximately
three days earlier than control ewes, but are not sure of the reason why. This link is
suggested because cortisol normally increases during late gestation and at parturition, as
does plasma leptin and peri-renal mRNA expression (Magyar et al., 1980; O’Connor et
al., 2007). However, this increase in leptin and leptin mRNA expression does not occur
when the adrenal glands are removed (O’Connor et al., 2007). Additionally, Mustoe et al.
(2012) showed that in marmoset monkeys, infants born to mothers with increased
gestational cortisol for the first trimester of gestation had reduced fetal growth rates.
However, these high-cortisol infants had more rapid postnatal growth rates than control
infants, and experienced complete compensatory growth by 540 days of age. Thus it is
possible that elevated cortisol concentrations are responsible for some sort of fetal
programming.
In rats from control-fed dams, circulating leptin was negatively correlated with
feed consumption, suggesting the proper leptin response (Delavaud et al., 2000). Rats
from nutrient-restricted mothers, however, had circulating leptin concentrations that were
positively correlated with feed consumption, suggesting leptin insensitivity or resistance
(Delavaud et al., 2000). During severe nutrient restriction, in the form of a two-day fast,
back, omental, and peri-renal adipose tissue leptin mRNA was decreased in ruminants,
suggesting a pre-translational regulation due to nutrient uptake (Kumar et al., 1998;
Tsuchiya et al., 1998). Perhaps a similar response occurs during prolonged nutrient
restriction while in utero.
Organ Size
Intrauterine growth retardation is also characterized by asymmetric organ growth.
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Organs such as the pancreas, liver, kidney (reduced as a percentage of body weight), and
lungs (reduced as a percentage of body weight) become reduced in size so that nutrient
priority is given to the brain (de Boo et al., 2008; Novitskaya et al., 2011). The brain has
a reduced absolute weight, but it is increased as a percentage of body weight (Novitskaya
et al., 2011). Vonnahme et al. (2003) found that when corrected for body weight, liver
weight and left and right heart ventricles were larger in IUGR lambs. This may be due to
an increase in liver metabolic activity (Vonnahme et al., 2003). Ruminants receive
glucose primarily via gluconeogenesis, and since IUGR results in reduced blood glucose
concentration, gluconeogenic enzymes in the fetal liver are increased (Lemons et al.,
1986; Vonnahme et al., 2003).
Hypertension
In addition to asymmetric heart growth, IUGR lambs have larger left and right
ventricles of the heart, suggesting increased ventricular afterload, which requires the
ventricle to overcome more force during contraction (Vonnahme et al., 2003). This can
be due to either aortic or pulmonary artery impedence, peripheral vascular resistance, or
viscosity of the blood (Vonnahme et al., 2003). In this case, Vonnahme et al. (2003)
suggested that it was to be due to increased placental vascular resistance, as vascularity of
the placenta did not change in IUGR lambs.
Growth-restricted lambs nutrient-restricted from early to mid-gestation have a
reduced number of kidney nephrons, which is associated with hypertension as well
(Gopalakrishnan et al., 2005). In cattle, Long et al. (2009) reported reduced glomerular
number in bovines on day 245 of gestation in IUGR calves, despite similar kidney
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weight, supporting the findings of Gopalakrishnan et al. (2005) that IUGR animals have
fewer nephrons.
Change in Tissue Accretion
Most fetal development involves an increase in cell number, or hyperplasia,
whereas postnatal development involves an increase in cell size, or hypertrophy. IUGR
animals have a physiological limit to growth, that is less than their genetic potential due
to fetal programming of the somatotropic axis (Boersma and Wit, 1997; Rehfeldt and
Kuhn, 2006). Consequently, bone and muscle will not reach the normal trajectory in an
IUGR animal with an altered somatotropic axis, even if postnatal compensatory growth
does occur. Instead, the compensatory growth experienced, will result in an increase in
size of adipose tissue, due to a change from normal nutrient partitioning once GH and
IGF-1 concentrations decrease (Boersma and Wit, 1997). De Blasio et al. (2010) found
increased peri-renal, retroperitoneal, and visceral fat in the carcasses of placentally
restricted lambs when compared to the control.
Rehfeldt and Kuhn (2006) examined the effects of birth weight on postnatal
myogenesis of pigs. In pigs, not only maternal nutrition, but also position in the uterine
horn, is responsible for the amount of nutrients received (Rehfeldt and Kuhn, 2006; Wu
et al., 2006). Since hyperplasia of myogenic cells is most prominent in prenatal growth,
whereas hypertrophy occurs predominantly postnatally, this reduced number of myogenic
cells limits animal growth for life. It was also determined that as the animals grew,
piglets with low birth weights experienced supramaximal growth of individual muscle
fibers, resulting in giant fibers, which grew beyond the parameters of normal growth
(Rehfeldt and Kuhn, 2006). Therefore, at slaughter, the low birth-weight pigs had not
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only a greater percentage of organ weight to body weight, as muscle growth was
restricted, but also had a greater percentage of adipose tissue, and a reduced quality of
meat (Rehfeldt and Kuhn, 2006).
Lambs from underfed ewes days 28 to 78 of gestation displayed increased back
fat (detected via ultrasound) at 140 days of age (Ford et al., 2007). Additionally, while
LM and semitendinosus muscle weights were similar for IUGR and control lambs, the
ratio of LM and semitendinosus muscle weights to hot carcass weights was less in IUGR
lambs (Ford et al., 2007).
Prevention and Reversal
Thus far, scientists have been unsuccessful in attempting to prevent or reverse
IUGR through hormone treatments. However, de Boo et al. (2008) attempted to reverse
IUGR in sheep by supplementing maternal GH through intramuscular injections. Three
groups of sheep were used: one control, and two with growth restriction induced twice
daily by embolization of the uterine arteries (de Boo et al., 2008). One of the IUGR
groups was treated by GH injection, and the other served as a control and was treated
with saline injection (de Boo et al., 2008). The IUGR induction reduced animal body
weight, and increased the mass of the liver, heart, thyroid, and peri-renal fat deposits (de
Boo et al., 2008). The GH treatment was able to improve fetal weight and overcome
decreased chest girth, as well as most of the decreases in organ size (de Boo et al., 2008).
However, even in GH-treated animals, the brain-to-liver weight ratio remained increased,
suggesting that exogenous GH treatment was not able to fully normalize organ growth
(de Boo et al., 2008). Additionally, some of the GH-supplemented lambs were found to
have severe brain lesions, which may be due to hyperglycemia during gestation (de Boo
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et al., 2008). Even though this experiment could not fully reverse IUGR, it was the first
study to suggest that, with more research, it could be possible to use hormone treatments
to prevent and reverse IUGR in animals (Setia and Sridhar, 2009).
Summary
The in-utero environment has lasting effects on offspring growth, specifically
through alterations in metabolic hormone concentrations as well as in receptor number,
and hormone response. The mechanisms by which these alterations occur are unknown.
We are trying to understand the metabolic changes that occur in offspring, both longterm
and short term as a result of poor maternal nutrition during gestation. This will hopefully
lead to a better understanding of the mechanisms involved, and ways to avoid negative
fetal programming in the future.
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Objectives and Hypotheses
My objectives in performing this experiment were three-fold. The normal model
in our laboratory when conducting a fetal programming experiment is to induce
nutritional insult to the mother during gestation, and then remove one of her lambs at
birth. The lamb is then bottle-fed until 60 days of age. For the first days postpartum,
lambs must be fed every 3 hours, which requires a significant work force to ensure
sufficient nutrition. It would be much more efficient to leave the lamb with the ewe to
nurse, but there has not yet been a comparison of the differences between bottle-feeding
and nursing the lambs in the response to nutritional insult to the ewe during gestation.
Although less expensive and less time consuming, there is the potential for more
variation in the offspring with nursing, including the nutritional quality of the milk from
nursing mothers. Thus, the first objective was to compare models of postnatal nutrition
for fetal programming experiments: bottle-feeding milk replacer (bottle lambs) compared
with leaving the lamb to nurse from the ewe (suckling lambs).
The second objective was to determine the long-term effects of poor maternal
nutrition during gestation, as far as one year after birth. Most of the research focuses on
short-term effects (90 days of age), but for maintaining herd health, as well as human
health, knowledge about long-term effects is essential.
The last objective was to determine if the ewes experienced any long-term affects
of poor diet. If poor gestational diet affects the ewes long-term, than it has the potential to
negatively impact the fetus she is carrying during the time of nutritional insult, but also
has the potential to affect the health of her future offspring.
Our hypotheses were that there would be no difference in results between bottle-
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fed lambs and suckling lambs. Additionally, we expected that lambs born to overfed and
nutrient-restricted ewes would be smallerwith a slower growth rate than lambs born to
control-fed ewes. In addition, these lambs would have alterations in concentrations of
circulating hormones of the somatotropic axis (GH, IGF-1, IGFBP-2, and -3), and leptin.
Lastly, we hypothesized that ewes would experience long-term effects of poor gestational
diet.
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Materials and Methods
For this study, 40 multiparous ewes from the UConn flock were synchronized for
estrus by intravaginal controlled internal drug release (CIDR) with 300 mg progresterone
for 11 days (EAZI-BREED CIDR, Pfizer). Upon removal, all ewes were given a single
20mg IM injection of PGF2α (Dixon et al., 2006). Pregnancy was later confirmed by
ultrasound.
Of these ewes, 36 were selected to use for the study, and were housed in
individual pens. There were 25 Dorsets, 7 Shropshires, and 4 Southdowns. These animals
were acclimated to a control diet for 1 week. At 31 days of gestation, each ewe was
randomly assigned to one of three diets (Vonnahme et al., 2010), 100%, 60%, or 140% of
NRC 1985 recommendations (n=12 per treatment). The amount fed was based on ewe
body weight. Leftover feed was removed every day, and weighed to determine daily feed
intake. Animals were also given ad libitum water. Ewes were fed a complete pelleted
feed from the Connecticut Farmers’ Co-op, in Manchester, CT. Straw was also provided
in the morning. Ewes were weighed, and the body condition score (BCS) was determined
weekly (Russel, 1984).
These ewes gave birth to a total of 68 lambs. The average gestation length was
143.9 days; there was no effect of treatment on length of gestation. The ewe and her
lambs were housed together in pens to allow for colostrum intake. All of the lambs
received colostrum from the ewe; if they had not nursed by one hour after birth, lambs
were intubated and given artificial colostrum. At 24 hours postpartum, 35 lambs were
removed from the ewe. If two ewes were born to the ewe, the largest ewe lamb was
removed from the mother. If one ewe and one ram were born, the ram was removed, and
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if two rams were born, the largest ram was removed. Eighteen of the lambs that were
removed from their mothers were randomly assigned to be euthanized by Beuthanasia IV
injection (sodium pentobarbital 390 mg + sodium phenytoin 50 mg/ml) at 0.22 ml/kg at
this time point (6C, 6R, 6O).
The remaining 17 lambs, 6 born to control-fed ewes, 6 born to overfed ewes, and
5 born to restricted ewes, that were removed from the ewe, were bottle fed Land O’Lakes
milk replacer at 1.7% of their body weight, as well as ad libitum second cutting hay, and
water. At 4 weeks, the start of weaning, BT creep feed was also given ad libitum. Body
weight was measured at birth, and every two days until the lambs were weaned, and then
every week until slaughter. Crown-rump length and heart girth were measured weekly.
From birth until the lambs were heavier than 4 kg, 10 mL of blood was collected weekly
via jugular venipuncture. Once the lambs were heavier than 4 kg, 20 mL of blood was
collected weekly until slaughter. These lambs were slaughtered at 13 weeks of age. At
slaughter, there were 6 lambs from control-fed ewes, 4 lambs from overfed ewes, and 4
lambs from restricted ewes.
Of the lambs born, 30 returned with the ewes as part of the UConn flock. There
were 9 lambs born to both control-fed and overfed ewes, and 12 lambs born to restrictedfed ewes that were monitored as part of this study. From these lambs, body weight,
crown-rump length, and heart girth were measured at birth, and then monthly for one
year. 10 mL blood was collected at birth via jugular venipuncture, and then 20 mL were
collected monthly for one year. By the end of the year, there were 4 lambs born to
control-fed ewes, 4 lambs born to overfed ewes, and 6 lambs born to restricted ewes.
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After parturition, all 36 ewes were returned to the flock to be maintained for
another breeding cycle. Body weight was measured at parturition, and then monthly for
12 months. At these same time points, 20 ml of blood was collected as well. By the end
of the 12 months, 20 ewes remained: 5 control, 9 restricted, and 6 overfed. Ewes were
removed from the study if their lamb was sent to auction before it was fully weaned.
Blood was collected into 3 different types of tubes: 14 mL was collected into
uncoated blood tubes, allowed to stand at room temperature for 3 hours to clot, and then
refrigerated overnight at 4°C before centrifugation. These tubes were used for serum
collection. An additional 3 ml was collected into a tube coated with heparin, and the
remaining 3 ml was collected into a tube coated with EDTA. Both of these tubes were
immediately placed on ice, and centrifuged upon return to the laboratory. These tubes
were used for plasma collection. Blood samples were centrifuged for 30 minutes at 1,200
x g at 4°C, and serum and plasma were isolated and frozen at -20°C until used. Serum
GH (Kazmer et al., 1992), and IGF-1 (Govoni et al., 2002), concentrations were
quantified (ng/ml) by radioimmunoassay (RIA). Plasma leptin concentrations were
quantified (ng/ml) by Millipore Multispecies Leptin RIA Kit (Long et al., 2010). IGFBP2 and IGFBP-3 were quantified by Western Blot (Freake et al., 2001; Govoni et al.,
2002). Proteins were separated using SDS-PAGE, with serum concentration at 1 µL per
well in the gel. Proteins were then transferred to a nitrocellulose membrane (BioRad
Laboratories, Hercules, CA), and incubated overnight with 300,000 cpm of radioactive
125

I-IGF-1 (Perkin Elmer, Shelton, CT). Membranes were then washed to remove any

unbound IGF-1, and the blot was imaged after membrane incubation with a multipurpose
phosphor screen (Packard Instrument Company, Meriden, CT). The remaining bound
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radioactivity was imaged using a Cyclone Storage Phosphor system (Packard Instrument
Company), and were quantified using OptiQuant software. Digital light units were
quantified, and values were expressed relative to a bovine standard included on every gel
as a control.
Growth rate was determined by subtracting the body weight at birth from the
body weight at 9 months of age, and dividing by the number of days of age. Lontitudinal
measurements of body weight, crown-rump length, heart girth, serum GH, IGF-1, and
IGFBP-2, and -3, and leptin were analyzed statistically as repeated measures, using a
model that accounted for repeated samples from the same experimental unit, with the
mixed model analysis of variance procedure (SAS Inst. Inc., Cary, NC). Multiple
methods of analysis were used, but the final method was chosen as best fit for the data set
based on the smallest AIC value. Differences were considered significant if P < 0.05 and
were considered a trend if 0.05 < P < 0.1.
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Results
Suckling vs. Bottle-fed Lambs
Over time, all lambs increased body weight from 4.5 ± 0.21 kg at birth to 34.7 ±
0.68 kg at 3 months. At birth, the largest lamb was removed from the ewe and bottle-fed,
so bottle lambs (n=17) weighed more at birth than suckling lambs (n=30); (5.0 ± 0.17 kg
vs. 4.3 ± 0.13 kg; P < 0.01). By 1 month the suckling lambs weighed significantly more
than the bottle lambs (15.4 ± 0.59 kg vs. 10.7 ± 0.75 kg; P < 0.01). This greater body
weight was maintained (36.6 ± 0.56 kg vs. 30.8 ± 0.73 kg; P < 0.01) through 3 months of
age (Table 1, Figure 1).
All lambs increased in size gaining approximately 39.3 ± 1.0 cm in CRL, and 38.9
± 0.7 cm in heart girth over 3 months. Based on selection criteria, the bottle lambs had a
larger CRL (48.2 ± 0.9 cm) at birth than the suckling lambs (47.4 ± 0.8 cm), although the
difference was not statistically significant (P = 0.49). At 1 month, the suckling lambs
were significantly larger than the bottle lambs (70.9 ± 0.8 cm vs. 61.3 ± 0.9 cm; P <
0.01). At 3 months of age, the difference in CRL was reduced to almost 5 cm but
remained significant (89.1 ± 0.8 vs. 83.7 ± 1.1 cm; P < 0.01); (Table 2, Figure 2). Bottle
lambs had a heart girth that was significantly larger than the suckling lambs (39.6 ± 0.6
cm vs. 37.6 ± 0.4 cm; P < 0.01) at birth, but by 1 month of age, the suckling lambs had a
significantly larger heart girth (59.4 ± 0.7 vs. 50.7 ± 0.9 cm; P < 0.01). By 3 months, the
difference in heart girth was reduced (78.7 ± 0.8 cm vs. 74.5 ± 0.9 cm; P < 0.01),
however, the suckling lambs remained significantly larger (Table 3, Figure 3).
At birth, the suckling lambs and bottle lambs had similar concentrations of
circulating IGF-1 (109 ± 14.9 ng/ml vs. 133.0 ± 19.1 ng/ml, respectively; P = 0.33), as
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this was before treatment implementation. At 1 month, the suckling lambs had a
significantly greater (P < 0.01) IGF-1 concentration (280.7 ± 22.9 ng/ml) than the bottle
lambs (64.9 ± 28.4 ng/ml). At 2 and three months, there was no significant difference in
suckling and bottle lamb IGF-1 concentration (231.5 ± 22.9 ng/ml vs. 173.3 ± 28.7 ng/ml,
and 211 ± 19.9 ng/ml vs. 177.9 ± 26.5 ng/ml; P = 0.27 and 0.72 respectively).
All lambs experienced a decline in GH concentration with age, with suckling
lambs going from 13.4 ± 3.2 ng/ml at birth to 5.5 ± 3.1 ng/ml at 3 months, and bottle
lambs going from 11.1 ± 3.4 ng/ml at birth to 3.8 ± 3.4 ng/ml at 3 months. There was no
difference in circulating GH concentration between bottle lambs and suckling lambs (P =
0.698; Table 5, Figure 5).
Bottle lambs tended to have less circulating IGFBP-3 (111.71 ± 7.3 AU) than
suckling lambs (130.77 ± 6.4 AU; P = 0.0633). At birth, IGFBP-3 concentrations are
similar, as expected, but at 1 month, suckling lambs have a significantly increased
IGFBP-3 concentration (P < 0.01; Table 6, Figure 6). At 2 months, after the start of
weaning, bottle lambs have more IGFBP-3 than suckling lambs, although not significant
(P = 0.373).
There was no significant difference in bottle and suckling lamb leptin
concentration through 3 months of age (P = 0.58). At birth, bottle lambs had more
circulating leptin than suckling lambs (1.5 ± 0.2 ng/ml vs. 1.2 ± 0.2 ng/ml). By 3 months
of age, the suckling lambs had a greater circulating leptin concentration compared with
the bottle lambs (1.3 ± 0.2 ng/ml vs. 1.1 ± 0.2 ng/ml; P = 0.23; Table 7, Figure 7).
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Suckling Lambs Long-Term
All suckling lambs increased in body weight from approximately 4.3 ± 1.5 kg at
birth to 68.3 ± 2.0 kg at 9 months of age. There was no difference in suckling lamb
body weight over time (CON vs. RES P = 0.36; CON vs. OVER P = 0.96), with lambs
born to ewes of all 3 treatment groups gaining an average of 0.24 kg/day. At birth, lambs
born to control-fed, overfed, and restricted ewes (abbreviated CON, RES, and OVER
lambs) weighed 4.4 ± 1.6 kg, 4.0 ± 1.4 kg, and 4.6 ± 1.6 kg respectively (CON vs. RES,
P = 0.92; CON vs. OVER, P = 0.88). At 9 months, these lambs weighed 69.2 ± 1.9 kg,
66.4 ± 1.8 kg, and 70.4 ± 2.1 kg (CON vs. RES P = 0.66 and CON vs. OVER P =0.29)
(Table 8, Figure 8).
Over the 9-month period, all suckling lambs also increased in size, gaining
approximately 63.1 ± 2.8 cm in CRL, and 67.3 ± 1.5 cm in heart girth. There was no
significant difference in CRL between CON, RES, and OVER lambs from birth to 9
months of age. (P = 0.6374, OVER vs. CON; P = 0.9432, for RES vs. CON); (Table 9,
Figure 9). Similarly, there was no significant difference in heart girth between OVER and
CON lambs (P = 0.1622) or between RES and CON lambs (P= 0.4491); (Table 10
Figure 10). However, at 9 months, Over lambs have a significantly larger (P < 0.01)
heart girth compared with Con lambs (108.9 ± 1.8 cm vs. 102.8 ± 2.0 cm).
Additionally, over time, there was no difference in circulating IGF-1
concentrations between OVER and CON lambs (144.3 ± 15.4 ng/ml vs. 136.3 ± 14.5
ng/ml; P = 0.71) or between RES and CON lambs (133.4 ± 13.2 ng/ml vs. 136.3 ± 14.5
ng/ml; P = 0.88; Table 11, Figure 11). At 1 month, CON lambs have a reduced IGF-1
concentration compared with both OVER and RES lambs (253.2 ± 28.1 ng/ml vs. 323.2 ±
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40.5 ng/ml and 270.8 ± 37.9 ng/ml), which is interesting because at birth, CON lambs
had the highest IGF-1 concentration. This difference is not significant (P = 0.21 and
0.74). Additionally, at 2 months, OVER lambs had a greater IGF-1 concentration
compared with CON lambs (P < 0.01). This suggests possible increased intake in OVER
and RES lambs, and therefore compensatory growth.
All suckling lambs experienced an age-related decrease in circulating GH
concentration. However, there was no significant difference in circulating lamb GH
concentration between OVER and CON (P = 0.9591) or between RES and CON (P =
0.7984) lambs at any time point (Table 12, Figure 12).
OVER lambs had significantly more IGFBP-3 than CON lambs (167.4 ± 7.3 AU
vs. 137.7 ± 6.6 AU; P < 0.05), but there was no difference between RES and CON lambs
(122.2 ± 6.37 AU vs. 137.7 ± 6.6 AU; P = 0.1063). At 6 months, there was a trend for
RES lambs to have less IGFBP-3 than CON lambs (128.1 ± 19.8 AU vs. 184.6 ± 22.2
AU; P < 0.1), and at 9 months, RES lambs had significantly less IGFBP-3 than CON
lambs (116.4 ± 11.8 AU vs. 155.7 ± 13.3 AU; P < 0.05) (Table 13, Figure 13). Although
at birth, RES lambs tended to have less IGFBP-2 than CON lambs (P < 0.1), there was
no difference in circulating IGFBP-2 among all lambs over time (16.5 ± 1.4 AU vs. 18.9
± 1.6 AU; P = 0.2979 for CON vs. RES; 17.4 ± 1.7 vs. 18.9 ± 1.6 AU; P = 0.5364 for
CON vs. OVER; Table 14, Figure 14). All lambs experienced an age-related decrease in
IGFBP-2.
There was no difference in circulating lamb leptin concentration between OVER
and CON (P = 0.6635) or between RES and CON (P = 0.1651) lambs (Fig. 12). All
lambs experienced a leptin peak around 5 months of age, at which point there was a trend
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for RES lambs to have less circulating leptin than CON lambs (2.8 ± 0.3 ng/ml vs. 2.1 ±
0.3 ng/ml; P < 0.1) At 6 months, there was no difference in lamb leptin concentration
(Table 15, Figure 15).
Ewes
At birth, RES ewes weighed significantly less than CON ewes (99.6 ± 3.6 kg vs.
113.8 ± 3.5 kg; P = 0.01). Once ewes were returned to the flock, 3 days after parturition,
they were all maintained on a control diet. Even so, OVER ewes maintained a 5 kg
weight increase OVER the 9 month period, and RES ewes maintained a 7 kg weight
decrease. There was no significant difference between these body weight differences (P
= 0.3442 for CON vs. OVER, and 0.1358 for CON vs. RES; Table 16, Figure 16).
Over time, OVER ewes had significantly more circulating IGF-1 than CON ewes
(194.19 ± 129.9 ng/ml vs. 130.1 ± 102.5 ng/ml; P < 0.05), and there was a trend for RES
ewes to have less circulating IGF-1 than CON ewes at birth, 1 month, and 5 months (P <
0.1). However, over time, there was no difference between RES and CON ewe IGF-1
concentration (122.29 ± 61.9 ng/ml vs. 130.1 ± 102.5 ng/ml; P = 0.12; Table 17, Figure
17).
There was no significant difference in circulating GH concentration between
OVER and CON ewes (2.9 ± 0.9 ng/ml vs. 1.9 ± 0.9 ng/ml; P = 0.4716). However, RES
ewes had significantly more circulating GH than CON ewes (averaging 4.4 ± 0.8 ng/ml
vs. 1.9 ± 0.9 ng/ml; P < 0.01; Table 18, Figure 18).
OVER ewes maintained a significantly increased IGFBP-3 concentration as long
as 9 months postpartum compared with CON ewes (408.1 ± 35.5 AU vs. 287.9 ± 43.5
AU; P < 0.05), but there was no difference between RES (240.1 ± 31.4 AU) and CON
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(287.9 ± 43.5 AU) ewes (P = 0.4914). All ewe IGFBP-3 concentrations decreased after
parturition, and began to increase at 6 months (Table 19, Figure 19). At parturition
OVER ewes had significantly less circulating IGFBP-2 (29.35 ± 2.7 AU vs. 33.2 ±
3.3AU; P < 0.05), however this difference was not maintained through 9 months, and
there was no difference over time between CON (24.4 ± 1.7 AU), RES (21.3 ± 1.4 AU),
and OVER lambs (24.7 ± 1.2 AU) IGFBP-2 concentrations (P = 0.8682 for CON vs.
RES; P = 0.1687 for CON vs. OVER ) (Table 20, Figure 20.
There was a trend for OVER ewes to have more circulating leptin than CON ewes
(2.6 ± 0.2 ng/ml vs. 1.8 ± 0.3 ng/ml; P < 0.1), but there was no difference in circulating
leptin concentration between RES and CON ewes (2.0 ± 0.2 ng/ml vs. 1.8 ± 0.3 ng/ml; P
= 0.43; Table 21, Figure 21).
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Discussion
Bottle lambs were larger at birth, but suckling lambs grew at a faster rate, and by
1 month of age, were larger than bottle lambs. They maintained this larger size and
heavier body weight through 3 months. Suckling lambs had an average daily gain of 0.38
kg/day compared with 0.3 kg/day for the bottle lambs. From 1 to 3 months of age, it
appears that the suckling and bottle lambs were growing at the same rate, but from birth
to 1 month, the suckling lambs have an increased growth rate. Emsen et al. (2004) had
similar findings: lambs fed a calf milk replacer, although larger at birth, gained less
weight than lambs left to nurse naturally from the ewe in an arid environment. In our
study, however, the lambs were not fed calf milk replacer, the bottle lambs were weaned
later, and ewes were fed significant nutrients during lactation. Emsen et al. (2004) noted
that bottle lambs maintained their smaller size through 6 weeks of age, 2 weeks post
weaning in their study. However, it has been shown by Heaney et al. (1982) that lambs
grow better on lamb milk replacer than calf milk replacer; thus it appears as though the
Emsen study was conducted to obtain results for a farmer struggling with the cost of
raising his flock.A similar trend is seen for crown-rump length and heart girth, where
suckling lambs are larger than bottle lambs by 1 month, and maintain this increased size
through 3 months of age.
At birth, suckling and bottle lambs had similar IGF-1 concentrations, as was
expected since the lambs were not yet assigned to a treatment at this point. At 1 month of
age, the suckling lambs had a greater IGF-1 concentration. Increased IGF-1 is associated
with increased growth rate (Yakar et al., 1999), which supports the increase in body
weight and body size of the suckling lambs at 1 month of age. From birth to 1 month, the
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bottle lambs experienced decreased IGF-1. Since IGF-1 is associated with nutritional
intake (Baumann, 2009), this suggests restricted intake in the bottle lambs, especially
since IGF-1 concentrations increased after 1 month, the time of the start of weaning.
After 1 month, IGF-1 concentrations in the bottle lambs increased, and the magnitude of
the difference in body size and body weight between suckling and bottle lambs decreased
as well.
Associated with this reduction in IGF-1 in the bottle lambs at 1 month of age was
increased GH. Although not statistically significant, bottle lamb GH concentrations were
increased at this time point. As the somatotropic axis is regulated through a negative
feedback loop, GH was increased in an attempt to increase IGF-1 concentrations
(Giustina et al., 2008). This supports the hypothesis that bottle lamb intake was restricted.
Additionally, suckling lambs tended to have increased circulating IGFBP-3
compared with bottle lambs. A greater IGFBP-3 concentration is associated with an
increased rate of growth (Govoni et al., 2005; Sabin et al., 2011). Thus the greater
IGFBP-3 concentration, specifically at 1 month of age, supports our hypothesis that
suckling lambs had access to more nutrition than the bottle lambs before weaning. At 2
months, bottle lambs have more circulating IGFBP-3, although not statistically
significant. This suggests that at the start of weaning, bottle lambs began to experience
compensatory growth.
Over time, circulating leptin concentrations in bottle lambs decreased, whereas
leptin concentration in suckling lambs increased, and by 3 months of age, suckling lambs
had a greater circulating leptin concentration compared with bottle lambs. Leptin
concentrations are positively correlated with body weight and adiposity (Delavaud et al.,
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2000), which suggests that the increase in body weight and body size in suckling lambs is
at least in part due to an increase in adipose tissue, and not just increased muscle tissue.
To determine if adiposity was increased, BCS was compared in the bottle lambs and
suckling lambs at 2 and 3 months. The average BCS of bottle lambs for these time points
was 2.9, whereas average BCS in suckling lambs was 3.1. Although only a slight
difference, this difference does support the suggestion that the increased body weight in
the suckling lambs is due to adipose tissue accumulation, and not muscle tissue
accumulation.
Therefore, although the suckling lambs were heavier and larger than the bottle
lambs, this does not necessarily mean that leaving the lamb to nurse from the ewe is a
better model of postpartum nutrition for a fetal programming study. Bottle-feeding the
lambs controls the nutrient amount as well as quality of the milk, and as of yet, there has
not been any research into how the maternal ability to produce milk is affected after a
period of nutritional stress. Thus, lambs born to underfed and overfed ewes may
experience differences in milk quality if left to nurse with the ewe. This would make the
postnatal diets variable amongst lambs. However, quantity and quality of ewe milk was
not measured. Therefore, it is possible that for each ewe that gave birth to twins, the lamb
that returned to the flock is eating enough for two, or at least more than the bottle lambs.
This is supported by our data, which show that the bottle lambs grew slower before the
period of weaning than suckling lambs, with reduced IGF-1 concentrations, compared
with the suckling lambs. This suggests that feeding the bottle lambs milk replacer at 1.7%
body weight per feeding is not enough nutrition for the bottle lambs. Our hypothesis that
bottle lambs were not being fed enough pre-weaning is supported by increased growth
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rates and IGF-1 concentrations after the start of weaning, when access to grain becomes
available, and when the rumen begins functioning. Our laboratory will continue to study
this.
There was no long-term effect of maternal diet during gestation on lamb body
weight or body size. This is particularly interesting because in the bottle-fed lambs,
OVER lambs were significantly larger than CON lambs in all of these linear
measurements through 3 months of age.
There was no significant difference in circulating IGF-1 concentration in lambs
born to ewes of all 3 treatment groups. However, at birth, CON lambs have greater
concentrations of circulating IGF-1 than RES or OVER lambs. At 1 month of age, both
OVER and RES lambs have more IGF-1, and at 2 months, OVER lambs have
significantly more IGF-1. Although not all of these differences were statistically
significant, this increase in RES and OVER IGF-1 concentration is potentially due to
increased intake in an attempt to maintain a normal growth rate. As growth is, in part,
mediated by IGF-1 concentration, increased IGF-1 does suggest increased growth rate
(Baumann, 2009). However, there was no difference in lamb body weight to support this.
There was also no difference in circulating GH concentration, which supports our finding
that there was no significant difference in circulating IGF-1 concentrations, and does not
support the idea of compensatory growth. The increased OVER lamb GH concentration
at 6 months is due to 1 animal with a GH concentration of 19.65 ng/ml, while the average
concentration of the other 3 lambs is 0.98 ± 0.49 ng/ml. Due to the size of the standard
deviation, this large point was not considered an outlier, and could not be removed.
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OVER lambs had significantly more IGFBP-3 than CON lambs as far as 9 months
of age. At 6 months, the large difference between OVER and CON lamb IGFBP-3
concentration is due to one sample that was much larger (538.3 AU) than the others,
which averaged 257.0 ± 48.8 AU. This point was not considered an outlier, and therefore
could not be removed. More IGFBP-3 is associated with an increased rate of growth
(Govoni et al., 2005; Sabin et al., 2011), and as there was no difference in average daily
gain among CON, RES, and OVER lambs it is possible that increased IGFBP-3
concentrations in OVER lambs modulated compensatory growth in these animals. At
birth, there was a trend for RES animals to have reduced IGFBP-2, however over time
there was no difference in lamb IGFBP-2 concentration. IGFBP-2 is associated inversely
with animal body mass index (Mattsson et al., 2008), suggesting that there is no
difference in the ratio of muscle tissue to adipose tissue in these lambs. All lambs
experienced an age-related decrease in IGFBP-2 concentration.
There was also no difference in circulating leptin, which was supports the similar
IGFBP-2 concentrations, lack of compensatory growth, and a lack somatotropic axis
dysregulation, which was unexpected. We expected that RES and OVER lambs would
experience somatotropic axis dysregulation due to abnormal concentrations of IGF-1 and
GH in-utero. Once born, we expected to see compensatory growth in these animals,
associated with significantly greater leptin concentrations, which would mean an increase
in adipose tissue accumulation rather than muscle growth. However, differences in IGF-1
concentration were non-significant, suggested similar nutrient intake among lambs, and
similar rates of growth. The lack of effect of maternal diet during gestation could be due
to differences in maternal milk nutrition or due to the time of nutrient stress imposed
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during gestation. For example, different times of nutrient stress have different effects
(Vonnahme et al., 2003; Gardner et al., 2005; Ford et al., 2007; Coupé et al., 2012).
Lastly, the ewes experienced long-term effects of gestational diet. OVER ewes
maintained a 5 kg heavier body weight compared with CON ewes as far as 9 months
postpartum, and RES ewes maintained a 7 kg lighter body weight over the 9 month
period. Neither of these differences in body weight were statistically significant,
however. We did expect some initial differences in body weight as the ewes would take
some time re-alimenting to the control diet to make up for body weight differences.
However, we were not expecting that body weight would remain different through 9
months of being maintained on the same diet.
We expected that the OVER ewes would display greater IGF-1 concentrations
short-term, and that RES ewes would display reduced IGF-1 concentrations short-term,
due to differences in gestational diet. However, since IGF-1 is impacted by nutrition, we
expected that IGF-1 concentrations would quickly return to normal concentrations among
the three treatment groups. However OVER ewes had significantly greater circulating
IGF-1 compared with CON ewes over the 9 months, and there was a trend for RES ewes
to have reduced circulating IGF-1 at birth, 1 month, and 5 months. For this reason, it is
particularly interesting that RES ewes had a significantly greater circulating GH
concentration than CON ewes, but that there was no difference between CON and OVER
GH concentration. We expected that since OVER ewes displayed greater IGF-1
concentrations, that they would have had reduced GH, and that since there was no
significant difference between RES and CON ewe IGF-1 concentrations, there would not
be a difference in GH concentration. However, this was not the case, and there are times

45

when GH trends between GH concentration and IGF-1 concentration do not match. This
is perhaps more evidence that the ewes maintain longterm effects of poor gestational diet.
The increased CON ewe GH concentration at 8 months is due to 1 animal, with a GH
concentration of 7.74 ng/ml. At 8 months, the remaining CON ewes have an average GH
concentration of 0.81 ± 0.21 ng/ml. However, due to the magnitude of the standard
errors, the value can not be considered an outlier, and remained in the dataset.
Overfed ewes maintained significantly increased IGFBP-3 concentrations as far
as 9 months postpartum, possible due to increased intake after parturtion. There was no
difference between RES and CON ewe IGFBP-3 concentration. All ewe IGFBP-3
concentrations declined after parturition and began to increase around 6 months, the time
at which ewes were re-bred and moved from pasture grazing to the barn, where
supplemental grain was added to ewe diets. IGFBP-3 concentrations continued to
increase as gestation progressed. At parturition, OVER ewes had significantly less
IGFBP-2 than CON ewes, which makes sense as IGFBP-2 is inversely related to body
mass index (Mattsson et al., 2008). However, there was no difference between RES,
CON, and OVER ewe IGFBP-2 concentration over time.
Overfed ewes maintained increased circulating leptin concentrations relative to
the control ewes through 8 months postpartum. This indicates that even as late as 8
months postpartum, overfed ewes still have more adipose tissue, and are still
experiencing effects of their gestational diet. After the ewes were returned to the flock
postpartum, they were maintained as part of the flock; which included re-breeding. At
this point, the ewes have lambed this year’s offspring, which are very likely to be
affected by the gestational diets of these ewes last year. Therefore, it does seem that a
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period of nutritional stress during pregnancy has the potential to affect not only the
offspring a gestating mother is carrying during the time of nutritional stress, but also all
future offspring of that animal.
In summary, suckling lambs grew to be larger than bottle lambs, and had
increased concentrations of IGF-1 and leptin, suggesting increased intake. As ewe milk
quantity or quality was not measured, it is possible that there was variation in intake
among suckling lambs, making it difficult to compare the merit of the two postpartum
feeding models for a fetal programming experiment. There was no long-term difference
in growth or metabolic hormone concentration of suckling lambs, except that OVER
lambs had more circulating IGFBP-3 than CON lambs. This lack of difference is possibly
due to variation in postpartum intake due to maternal milk quality and quantity, as well as
the time of maternal nutrient stress. Lastly, ewes did experience longterm effects of poor
gestational diet. OVER ewes maintained a non-significant increased weight, and
significantly more circulating IGF-1, IGFBP-3, and leptin. RES ewes maintained
significantly increased GH. This suggests that when these ewes lamb again, it is possible
that these offspring will be affected by the poor nutritional conditions during the previous
gestation.
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Table 1: Suckling vs. Bottle Lamb Body Weight
Body
Birth
1 Month
2 Months
Weight, kg
5.0 ± 0.17
10.7 ± 0.75
20.6 ± 0.75
Bottle
Lambs

3 Months
30.8 ± 0.73

Suckling
Lambs

4.3 ± 0.13

15.4 ± 0.59

26.4 ± 0.59

36.6 ± 0.56

P-value

0.0016

<0.0001

<0.0001

<0.0001

At birth, bottle lambs weighed significantly more than suckling lambs (P < 0.01), but at
1 month, suckling lambs were approximately 5 kg heavier than bottle lambs (P < 0.01).
This significance remained through 3
months.
Tables and Figures

Table 2: Suckling vs. Bottle Lamb CRL
CRL, cm
Birth
1 Month

2 Months

3 Months

Bottle
Lambs

48.2 ± 0.9

61.3 ± 0.9

71.6 ± 0.9

83.7 ± 1.1

Suckling
Lambs

47.4 ± 0.8

70.9 ± 0.8

80.1 ± 0.8

89.1 ± 0.8

P-value

0.488

<0.0001

<0.0001

0.0001

At birth, bottle lambs were larger in CRL than suckling lambs, though this difference
was not significant (P = 0.488), but at 1 month, suckling lambs were approximately 10 cm
larger than bottle lambs (P < 0.01). This significance remained through 3 months.
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Table 3: Suckling vs. Bottle Lamb Heart Girth
Heart Girth,
Birth
1 Month
2 Months
cm
Bottle
39.6 ± 0.6
50.7 ± 0.9
64.2 ± 0.9
Lambs

3 Months
74.5 ± 0.9

Suckling
Lambs

37.6 ± 0.4

59.4 ± 0.7

69.9 ± 0.8

78.7 ± 0.8

P-value

0.0061

<0.0001

<0.0001

0.0011

At birth, bottle lambs were significantly larger in heart girth than suckling lambs (P <
0.01), but at 1 month, suckling lambs were approximately 8 cm larger than bottle lambs
(P < 0.01). This significance remained through 3 months

Table 4: Suckling vs. Bottle Lamb IGF-1 Concentration
IGF-1,
Birth
1 Month
2 Months
ng/ml
Bottle
133.0 ± 19.1 64.9 ± 28.4 173.3 ± 28.7
Lambs

3 Months
177.9 ± 26.5

Suckling
Lambs

109.1 ± 14.9

280.7 ± 22.9

231.5 ± 22.9

211.0 ± 19.9

P-value

0.3259

<0.0001

0.1156

0.3204

At birth, bottle and suckling lambs had similar IGF-1 concentrations (P = 0.326), but at
1 month, suckling lambs had a significantly increased IGF-1 concentration, to 280.7 ±
22.9 ng/ml, compared with bottle lambs (P < 0.01). At 3 months, IGF-1 concentrations
were similar again among the lambs (P = 0.32).
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Table 5: Suckling vs. Bottle Lamb GH Concentration
GH, ng/ml
Birth
1 Month
2 Months

3 Months

Bottle
Lambs

11.1 ± 3.4

11.2 ± 3.8

4.4 ± 1.3

3.8 ± 3.4

Suckling
Lambs

13.4 ± 3.2

9.6 ± 3.5

6.4 ± 1.2

5.5 ± 3.1

P-value

0.6154

0.7601

0.2693

0.7173

There was no significant difference in bottle and suckling lamb GH concentration from
birth to 3 months of age (P = 0.698). All lambs experienced an age-related decrease in GH
concentration.

Table 6: Suckling vs. Bottle Lamb IGFBP-3 Concentration
IGFBP-3,
AU

Birth

1 Month

2 Months

3 Months

Bottle
Lambs

79.8 ± 15.7

59.6 ± 16.5

200.8 ± 19.7

106.6 ± 16.3

Suckling
Lambs

66.7 ± 14.5

137.9 ± 15.1

177.8 ± 16.5

140.6 ± 14.8

P-value

0.5417

<0.01

0.373

0.1278

Over time, there was a trend for suckling lambs to have more IGFBP-3 than bottle lambs
(P = 0.0633).
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Table 7: Suckling vs. Bottle Lamb Leptin Concentration
Leptin,
Birth
1 Month
2 Months
ng/ml
Bottle
1.5 ± 0.2
1.4 ± 0.2
0.9 ± 0.2
Lambs

3 Months
1.1 ± 0.2

Suckling
Lambs

1.2 ± 0.2

1.4 ± 0.2

1.1 ± 0.2

1.3 ± 0.2

P-value

0.17

0.69

0.25

0.23

Although there was no significant difference in bottle and suckling lamb circulating leptin
concentrations (P = 0.58), bottle lambs had more circulating leptin at birth compared with
suckling lambs, and less circulating leptin at 3 months, suggesting suckling lambs had
greater adipose tissue accumulation.
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Table 8: Suckling Lamb Body Weight Over Time
BW, kg
Birth
3 Months
6 Months
CON
4.4 ± 1.6
36.8 ± 1.6
60.1 ± 1.8

9 Months
69.2 ± 1.9

OVER

4.6 ± 1.6

36.9 ± 1.7

60.0 ± 1.9

70.4 ± 2.1

RES

4.0 ± 1.4

35.9 ± 1.5

58.0 ± 1.7

66.4 ± 1.8

CON vs.
OVER Pvalue
CON vs. RES
P-value

0.92

0.97

0.97

0.66

0.88

0.68

0.34

0.29

There was no difference in suckling lamb body weight across the 3 treatment groups, with
all lambs gaining approximately 0.24 kg/day over the 9 month period (P = 0.36 for CON
vs. RES; P = 0.96 for CON vs. OVER).

Table 9: Suckling Lamb CRL
CRL, cm
Birth
CON
47.5 ± 2.5

3 Months
87.9 ± 2.4

6 Months
103.7 ± 1.9

9 Months
108.3 ± 3.0

OVER

46.8 ± 2.6

91.7 ± 2.5

106.2 ± 2.1

111.8 ± 3.0

RES

47.7 ± 2.3

87.9 ± 2.2

104.0 ± 1.8

111.2 ± 2.6

CON vs. OVER Pvalue
CON vs. RES Pvalue

0.85

0.26

0.38

0.41

0.96

0.97

0.64

0.55

There was no difference in suckling lamb CRL across the 3 treatment groups. (P = 0.943)
for CON vs. RES; P = 0.637 for CON vs. OVER).
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Table 10: Suckling Lamb Heart Girth Over Time
Girth, cm
Birth
3 Months
6 Months
37.5
±
0.9
78.4
±
1.6
97.4
± 2.0
CON

9 Months
102.8 ± 2.0

OVER

38.5 ± 0.9

80.8 ± 1.7

99.1 ± 2.1

108.9 ± 2.0

RES

37.1 ± 2.3

76.9 ± 1.6

94.9 ± 1.8

103.6 ± 1.8

CON vs.
OVER P-value
CON vs. RES
P-value

0.5

0.33

0.57

0.03

0.71

0.52

0.35

0.79

There was no difference in suckling lamb heart girth across the 3 treatment groups. (P =
0.449 for CON vs. RES; P = 0.162 for CON vs. OVER).

Table 11: Suckling Lamb IGF-1 Concentration
IGF-1, ng/ml
Birth
3 Months
6 Months
CON
137.7 ± 27.5 220.6 ± 24.8 89.1 ± 34.0

9 Months
89.0 ± 34.0

OVER

88.0 ± 29.2

219.1 ± 27.8

85.6 ± 34.3

68.2 ± 34.3

RES

100.9 ± 24.9

191.0 ± 24.6

91 ± 28.2

87.5 ± 28.2

CON vs.
OVER Pvalue
CON vs. RES
P-value

0.15

0.97

0.94

0.67

0.23

0.39

0.97

0.97

Over time, there was no difference in circulating IGF-1 concentration in suckling lambs
across the 3 treatment groups. P = 0.88 (CON vs. RES) and P = 0.71 (CON vs. OVER).
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Table 12: Suckling Lamb GH Concentration
GH, ng/ml
Birth
3 Months
CON
10.8 ± 3.0
3.9 ± 3.2

6 Months
2.4 ± 3.6

9 Months
2.6 ± 3.6

OVER

10.6 ± 3.2

4.6 ± 3.5

6.2 ± 3.8

1.9 ± 3.7

RES

12.9 ± 2.7

5.5 ± 3.1

3.0 ± 3.2

4.6 ± 3.1

CON vs.
OVER P-value
CON vs. RES
P-value

0.97

0.89

0.48

0.9

0.61

0.72

0.91

0.68

There was no difference in circulating GH concentration in suckling lambs over the 9
month period (P = 0.789 for CON vs. RES; P = 0.959 for CON vs. OVER). All
lambs experienced an age-related decrease in GH concentration.

Table 13: Suckling Lamb IGFBP-3
IGFBP-3, AU
Birth
3 Months
CON
66.3 ± 8.5
139.3 ± 15.8

6 Months
184.5 ± 22.2

9 Months
155.8 ± 13.3

OVER

54.7 ± 9.1

150.4 ± 17.9

334.0 ± 22.4

138.4 ± 13.8

RES

68.7 ± 7.7

132.8 ± 15.8

128.1 ± 19.8

116.4 ± 11.8

CON vs. OVER
P-value
CON vs. RES
P-value

0.35

0.64

<0.01

0.36

0.84

0.77

0.06

0.03

At birth, CON lambs had more circulating IGFBP-3 than OVER lambs but over time,
OVER lambs had significantly more IGFBP-3 than CON lambs (P < 0.05). There was no
difference in IGFBP-3 concentration between RES and CON lambs (P = 0.1063).
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Table 14: Suckling Lamb IGFBP-2
IGFBP-2, AU
Birth
3 Months
CON
32.1 ± 2.3
19.7 ± 2.2

6 Months
11.6 ± 3.2

9 Months
11.9 ± 0.79

OVER

28.6 ± 2.4

15.3 ± 2.4

13.7 ± 3.3

12.0 ± 0.79

RES

26.9 ± 2.0

18.6 ± 2.1

10.3 ± 2.7

10.4 ±0.64

CON vs. OVER
P-value
CON vs. RES
P-value

0.29

0.17

0.65

0.98

0.09

0.68

0.77

0.15

There was no difference in circulating IGFBP-2 concentration among CON, RES, and OVER
lambs (P = 0.2979 for CON vs. RES; P = 0.5364 for CON vs. OVER).

Table 15: Suckling Lamb Leptin Concentration
Leptin, ng/ml
Birth
3 Months
6 Months
CON
1.3 ± 0.2
2.2 ± 0.3
1.4 ± 0.2

9 Months
2.4 ± 0.3

OVER

1.1 ± 0.3

1.3 ± 0.3

2.9 ± 0.3

2.7 ± 0.3

RES

1.2 ± 0.2

1.3 ± 0.2

2.2 ± 0.3

2.1 ± 0.3

CON vs.
OVER Pvalue
CON vs. RES
P-value

0.37

0.86

0.17

0.56

0.65

0.89

0.91

0.6

There was no difference in circulating leptin concentration in suckling lambs over the 9
month period (P = 0.808 for CON vs. RES; P = 0.938 for CON vs. OVER).

55

Table 16: Ewe Body Weight
BW, kg
Birth
CON
113.8 ± 3.5

3 Months
93.4 ± 3.7

6 Months
88.1 ± 3.9

9 Months
94.6 ± 3.8

OVER

121.4 ± 3.5

99.3 ± 3.6

90.2 ± 3.7

97.7 ± 3.6

RES

99.6 ± 3.6

86.3 ± 3.6

82.4 ± 3.6

90.6 ± 3.6

CON vs.
OVER P-value
CON vs. RES
P-value

0.12

0.27

0.69

0.56

0.01

0.17

0.28

0.45

There was no significant difference in ewe body weigtht, (P = 0.34 CON vs. OVER, and
0.14 CON vs. RES) however OVER ewes did maintain a greater body weight as far as 9
months postpartum, and RES ewes maintained a reduced body weight.

Table 17: Ewe IGF-1 Concentration
IGF-1, ng/ml
Birth
3 Months
CON
361.4 ± 26.5 126.0 ± 31.2

6 Months
56.5 ± 34.7

9 Months
89.5 ± 34.7

OVER

568.3 ± 24.7

206.2 ± 26.4

98.5 ± 28.4

104.7 ± 28.4

RES

231.6 ± 23.4

176.2 ± 23.4

58.2 ± 26.3

77.4 ± 26.3

CON vs.
OVER P-value
CON vs. RES
P-value

<0.0001

0.046

0.35

0.74

0.0003

0.19

0.96

0.78

OVER ewes had a greater circulating IGF-1 concentration than CON ewes (P < 0.05) over the
9 month period. There was no difference between RES and CON ewe IGF-1 concentration
(P = 0.12).
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Table 18: Ewe GH Concentration
GH, ng/ml
Birth
3 Months
CON
7.1 ± 2.1
1.5 ± 3.0

6 Months
1.3 ± 3.3

9 Months
0.8 ± 3.3

OVER

5.8 ± 2.2

1.6 ± 2.8

1.1 ± 2.8

1.8 ± 2.8

RES

25.5 ± 2.1

2.1 ± 2.4

2.4 ± 2.4

1.5 ± 2.4

CON vs.
OVER Pvalue
CON vs. RES
P-value

0.66

0.96

0.96

0.8

<0.01

0.85

0.79

0.86

RES ewes had a greater circulating GH concentration than CON ewes (P < 0.01), but there
was no difference between OVER and CON ewes (P = 0.47).

Table 19: Ewe IGFBP-3 Concentration
IGFBP-3, AU
Birth
3 Months
CON
319.8 ± 107.7 102.8 ± 44.2

6 Months
225.7 ± 95.9

9 Months
503.2 ±
105.7

OVER

622.1 ± 87.9

186.1 ± 36.1

294.4 ± 78.3

529.7 ± 86.4

RES

206.3 ± 81.1

127.9 ± 31.9

231.1 ± 67.8

434.8 ± 74.8

CON vs.
OVER P-value
CON vs. RES
P-value

0.03

0.15

0.58

0.84

0.4

0.64

0.96

0.6

OVER ewes maintained a significantly increased IGFBP-3 concentration as far as 9 months
postpartum compared with CON ewes (P < 0.05).There was no difference between RES and
CON ewes (P = 0.4914).
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Table 20: Ewe IGFBP-2 Concentration
IGFBP-2, AU
Birth
3 Months
19.4 ± 3.3
CON
33.2 ± 3.3

6 Months
22.8 ± 3.3

9 Months
22.0 ± 3.3

OVER

29.3 ± 2.7

20.9 ± 2.7

21.1 ± 2.7

13.6 ± 2.7

RES

32.5 ± 2.3

21.1 ± 2.3

28.0 ± 2.3

17.3 ± 2.3

CON vs.
OVER Pvalue
CON vs. RES
P-value

0.03

0.15

0.58

0.84

0.4

0.64

0.96

0.6

At parturition, OVER ewes had significantly less circulating IGFBP-2 (P < 0.05), however
there was no difference in ewe IGFBP-2 concentration maintained through 9 months
postpartum (P = 0.8682 for CON vs. RES; P = 0.1687 for CON vs. OVER).

Table 21: Ewe Leptin Concentration
Leptin, ng/ml
Birth
3 Months
CON
1.5 ± 0.5
1.8 ± 0.3

6 Months
1.4 ± 0.5

9 Months
1.4 ± 0.5

OVER

2.6 ± 0.3

2.7 ± 0.4

2.0 ± 0.4

2.3 ± 0.4

RES

2.1 ± 0.3

1.7 ± 0.3

1.8 ± 0.3

1.9 ± 0.3

CON vs.
OVER Pvalue
CON vs. RES
P-value

0.08

0.03

0.31

0.16

0.57

0.72

0.49

0.4

OVER ewes tended to have more leptin over time than CON ewes (P <0.1), but there
was no difference between CON and RES ewes (P =0.42).
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Figure 1. Suckling lambs, although slightly lighter at birth, weighed
approximately 5 kg more at 1 month of age than the bottle lambs. This 5
kg weight difference was maintained through 3 months of age. * indicates
P < 0.01
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Figure 2. Suckling lambs experienced an increase in the rate of growth
from birth to 1 month of age compared with the bottle lambs. Thus at 1
month of age, they were 10 cm larger than the bottle lambs. At 3 months,
this difference was 5 cm, but was still present. * indicates P < 0.01
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Figure 3. Suckling lambs experienced an increase in the rate of growth
from birth to 1 month of age compared with the bottle lambs. At 1 month
of age, they were 8 cm larger than the bottle lambs. At 3 months, this
difference was reduced to 4 cm, but was still significant. * indicates P <
0.01
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Figure 4. Suckling lambs experienced an increase in IGF-1 concentration
from birth to 1 month of age compared with the bottle lambs, who
experienced a decrease. At 1 month of age, suckling lambs had an IGF-1
concentration that was greater than bottle lambs by 215 ng/ml. This
difference was less at 2 months of age, around the time of weaning, and
was 50 ng/ml at 3 months. * indicates P < 0.01
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Figure 5. All lambs experienced a decrease in GH concentration with age.
At 1 month, bottle lambs had an increased GH concentration compared
with the suckling animals, but this difference was not significant (P =
0.69). This is possibly because of the reduced IGF-1 concentration at this
time.
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Figure 6. Over time, bottle lambs tended to have a reduced concentration
of circulating IGFBP-3 compared with suckling lambs (P = 0.0633).
Suckling lamb IGFBP-3 concentration appeared to increase rapidly at 1
month of age, and at 2 months, bottle lamb IGFBP-3 concentration
increased, and caught up to suckling lamb IGFBP-3 concentration. *
indicates P < 0.05; # indicates 0.05 < P < 0.1
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Figure 7. Suckling lambs experienced an increase in leptin concentration
from birth to 1 month of age while bottle lambs experienced a decrease. At
1 month of age, suckling lambs had an increased leptin concentration,
which was maintained through 3 months. This greater concentration was
not statistically significant P =0.58
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Figure 8. There was no difference in body weight between CON and
RES lambs (P = 0.36) or between CON and OVER lambs (P = 0.96) over
the 9 month period. Lambs from all 3 treatment groups gained an
average of 0.24 kg/day.
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Figure 9. There was no difference in crown-rump length between CON and
RES lambs (P = 0.94) or between CON and OVER lambs (P = 0.64) over the
9 month period.
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Figure 10. There was no difference in heart girth between CON and RES,
lambs (P = 0.45) or between CON and OVER lambs (P = 0.16)over the 9
month period.
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Figure 11. There was no overall difference in circulating IGF-1 between
CON and RES lambs (P = 0.88) or between CON and OVER lambs (P = 0.71)
over the 9 month period. However at 2 months, OVER lambs had
significantly more (P < 0.05) IGF-1 than CON lambs. Average lamb IGF-1
concentration was 148.81 ± 98.1 ng/ml. * indicates P < 0.05
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Figure 12. There was no overall difference in circulating GH between CON
and RES lambs (P = 0.80) or between CON and OVER lambs (P = 0.96)
over the 9 month period. Lambs from all treatment groups experienced an
age-related decrease in GH concentrations. Average lamb GH
concentration was 4.03 ± 3.9 ng/ml.
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Figure 13. OVER lambs had greater circulating concentrations of IGFBP-3
than CON lambs (P < 0.05) over time, and at 6 (P = 0.06) and 9 months (P <
0.05), RES lambs have less IGFBP-3 than CON lambs. * indicates P < 0.05;
# indicates 0.05 < P < 0.1
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Figure 14. At birth, there was a trend for RES lambs to have less IGFBP-2
than CON lambs (P < 0.1). However, there was no difference in suckling
lamb IGFBP-2 concentration over time (P = 0.2979 for CON vs. RES; P =
0.5364 for CON vs. OVER). # indicates 0.05 < P < 0.1
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Figure 15. There was no overall difference in circulating leptin among
CON, RES, and OVER lambs over the 9 month period. Lambs from all
treatment groups had an average leptin concentration of 1.9 ng/ml.
However, at 5 months, RES lambs had significantly more (P < 0.05)
circulating leptin than CON lambs. * indicates P < 0.05
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Figure 16. There was no overall significant difference in ewe body weight
between birth and 9 months postpartum. However, RES ewes did
maintain a 7 kg reduced body weight, and OVER ewes maintained a 5 kg
body weight increase over CON ewes for the 9 months.
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Figure 17. Over time, OVER ewes had a greater circulating IGF-1
concentration than CON ewes (P < 0.05), but there was no difference
between RES ewes and CON ewes (P = 0.12) through 9 months
postpartum. At birth, 1 month, and 5 months RES ewes tended to have
reduced circulating IGF-1 (P < 0.1). CON ewes averaged an IGF-1
concentration of 151.7 ± 13.6 ng/ml, OVER ewes averaged a concentration
of 192.53 ± 11.9 ng/ml, and RES ewes averaged a concentration of 123.35
± 10.8 ng/ml. * indicates P < 0.05; # indicates 0.05 < P < 0.1
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Figure 18. Over time, RES ewes had a greater circulating GH concentration
than CON ewes (4.19 ± 7.72 ng/ml vs. 2.09 ± 2.39 ng/ml; P < 0.01), but
there was no difference between OVER (1.78 ± 1.8 ng/ml)and CON ewes
(P = 0.47). This figure does not include GH concentrations at birth because
the concentration was no much larger for RES ewes, that it skewed the
perception of the rest of the graph. * indicates P < 0.05
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Figure 19. OVER ewes had significantly more IGFBP-3 than CON ewes
as far as 9 months postpartum (P < 0.05). There was no difference
between RES and CON ewe IGFBP-3 concentration (P = 0.4914). *
indicates P < 0.05
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Figure 20. At parturition, OVER ewes had significantly less IGFBP-2
IGFBP
than CON ewes ((P < 0.05). However there was no difference
maintained over time among all ewes ((P = 0.8682 for CON vs. RES; P =
0.1687
.1687 for CON vs. OVER). * indicates P < 0.05
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Figure 21. OVER ewes tended to have more circulating leptin over time
than CON ewes (P < 0.1). There was no difference between CON and RES
ewe leptin concentration ((P = 0.42). Over the 9 months, CON ewes
averaged leptin concentrations of 1.76 ng/ml, RES ewes averaged 1.99
ng/ml, and OVER ewes averaged 2.63 ng/ml. # indicates 0.05 < P < 0.1.
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